GlassScriptPhysician profile
John A Pumphrey
NPI 1700833704
$5,957.83
in general payments reported to CMS, 2019-2025
43 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $1,410 · 2021: $327 · 2022: $296 · 2023: $185 · 2024: $2,042 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603 · Travel and Lodging: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,603.18 |
| Travel and Lodging | $598.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,145.96 | 2019-2020 | |
| Procept Biorobotics Corporation | $970.08 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $855.42 | 2019-2024 | Xtandi |
| Olympus America INC. | $280.06 | 2020-2025 | Itind System |
| Abbvie INC. | $270.89 | 2019-2025 | |
| Urogen Pharma, INC. | $248.22 | 2024-2025 | |
| Boston Scientific Corporation | $229.04 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue |
| Verity Pharmaceuticals INC. | $193.66 | 2024-2025 | Trelstar |
| Teleflex LLC | $184.88 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $177.18 | 2019-2024 | Akeega, Erleada |
| Axonics, INC. | $162.01 | 2021-2023 | Axonics |
| Coloplast Corp | $153.98 | 2022-2025 | Luja Coude |
| Blue Earth Diagnostics | $97.84 | 2019-2025 | Posluma |
| Immunitybio, INC. | $89.48 | 2025 | |
| Travere Therapeutics, INC. | $88.25 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $76.48 | 2025 | Ecoin Device Kit |
| Civco Medical Instruments | $51.21 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.22 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $46.51 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $45.75 | 2019 | |
| Myovant Sciences INC. | $41.06 | 2022 | |
| Laborie Medical Technologies Corp. | $39.03 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $35.84 | 2024-2025 | Cvac Aspiration System |
| Cook Medical LLC | $28.92 | 2024 | Resonance |
| 180 Medical, INC. | $27.75 | 2024 | Gentlecath Glide |
| Ferring Pharmaceuticals INC. | $26.87 | 2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $26.63 | 2024 | Keytruda |
| Antares Pharma, INC. | $25.36 | 2019-2025 | Xyosted |
| Innovation Technologies INC | $24.92 | 2024 | Irrisept |
| Photocure INC | $24.69 | 2024 | Cysview |
| Argon Medical Devices, INC. | $24.52 | 2024 | Clot Management |
| Azurity Pharmaceuticals, INC. | $22.23 | 2025 | Azmiro |
| Progenics Pharmaceuticals, INC. | $21.52 | 2024 | |
| Sumitomo Pharma America, INC. | $21.49 | 2024 | Orgovyx |
| Bioprotect Medical, INC. | $20.39 | 2024 | Bioprotect Balloon Implant System |
| Histosonics, INC. | $20.33 | 2024 | |
| Tolmar, INC. | $18.88 | 2025 | Eligard |
| Accord Healthcare, INC. | $18.79 | 2022 | |
| Telix Pharmaceuticals | $17.07 | 2024 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $15.39 | 2022 | |
| Urovant Sciences INC | $15.15 | 2022 | |
| Mission Pharmacal Company | $13.64 | 2019 | |
| Allergan, INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pumphrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.